呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

中药新药用于咳嗽变异性哮喘临床研究技术指导原则

2019-10-31 国家药品监督管理局药品审评中心（CDE）

咳嗽

中药新药用于咳嗽变异性哮喘临床研究技术指导原则

中文标题：

中药新药用于咳嗽变异性哮喘临床研究技术指导原则

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2019-10-31

简要介绍：

中药新药用于咳嗽变异性哮喘临床研究技术指导原则

相关资料下载：
[AttachmentFileName(sort=100, fileName=中药新药用于咳嗽变异性哮喘临床研究技术指导原则)] GetToolGuiderByIdResponse(projectId=1, id=7d8371c00181292b, title=中药新药用于咳嗽变异性哮喘临床研究技术指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=中药新药用于咳嗽变异性哮喘临床研究技术指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Thu Oct 31 04:38:27 CST 2019, originalUrl=, linkOutUrl=, content=中药新药用于咳嗽变异性哮喘临床研究技术指导原则, tagList=[TagDto(tagId=319, tagName=咳嗽)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2730, appHits=283, showAppHits=35, pcHits=1154, showPcHits=2044, likes=42, shares=26, comments=6, approvalStatus=1, publishedTime=Thu Oct 31 04:38:27 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 04:38:27 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 15:57:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中药新药用于咳嗽变异性哮喘临床研究技术指导原则)])
中药新药用于咳嗽变异性哮喘临床研究技术指导原则
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1189121, encodeId=e5ff1189121e0, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5f42283835, createdName=121cf7c6m25暂无昵称, createdTime=Sat Jan 29 17:49:36 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973359, encodeId=2bbd9e335984, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd125501997, createdName=ms7000002004416850, createdTime=Sun Jun 13 22:48:36 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968238, encodeId=a341968238e3, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/e3136d7ae5e74b9c85d6dbcec97426ae/143ef7bf243049cf88d9e74c587cab4f.jpg, createdBy=c68c5507072, createdName=Mizarius, createdTime=Mon May 24 21:10:20 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904279, encodeId=dc869042e938, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa225143193, createdName=1467e634m85暂无昵称, createdTime=Wed Dec 02 12:35:25 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2022-01-29 121cf7c6m25暂无昵称

    余额不足

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1189121, encodeId=e5ff1189121e0, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5f42283835, createdName=121cf7c6m25暂无昵称, createdTime=Sat Jan 29 17:49:36 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973359, encodeId=2bbd9e335984, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd125501997, createdName=ms7000002004416850, createdTime=Sun Jun 13 22:48:36 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968238, encodeId=a341968238e3, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/e3136d7ae5e74b9c85d6dbcec97426ae/143ef7bf243049cf88d9e74c587cab4f.jpg, createdBy=c68c5507072, createdName=Mizarius, createdTime=Mon May 24 21:10:20 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904279, encodeId=dc869042e938, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa225143193, createdName=1467e634m85暂无昵称, createdTime=Wed Dec 02 12:35:25 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-06-13 ms7000002004416850

    余额不足

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1189121, encodeId=e5ff1189121e0, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5f42283835, createdName=121cf7c6m25暂无昵称, createdTime=Sat Jan 29 17:49:36 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973359, encodeId=2bbd9e335984, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd125501997, createdName=ms7000002004416850, createdTime=Sun Jun 13 22:48:36 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968238, encodeId=a341968238e3, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/e3136d7ae5e74b9c85d6dbcec97426ae/143ef7bf243049cf88d9e74c587cab4f.jpg, createdBy=c68c5507072, createdName=Mizarius, createdTime=Mon May 24 21:10:20 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904279, encodeId=dc869042e938, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa225143193, createdName=1467e634m85暂无昵称, createdTime=Wed Dec 02 12:35:25 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-05-24 Mizarius

    余额不足

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1189121, encodeId=e5ff1189121e0, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5f42283835, createdName=121cf7c6m25暂无昵称, createdTime=Sat Jan 29 17:49:36 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973359, encodeId=2bbd9e335984, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd125501997, createdName=ms7000002004416850, createdTime=Sun Jun 13 22:48:36 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968238, encodeId=a341968238e3, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/e3136d7ae5e74b9c85d6dbcec97426ae/143ef7bf243049cf88d9e74c587cab4f.jpg, createdBy=c68c5507072, createdName=Mizarius, createdTime=Mon May 24 21:10:20 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904279, encodeId=dc869042e938, content=余额不足, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa225143193, createdName=1467e634m85暂无昵称, createdTime=Wed Dec 02 12:35:25 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-02 1467e634m85暂无昵称

    余额不足

    0

相关指南

咳嗽基层诊疗指南（实践版·2018）

中华医学会(CMA,Chinese Medical Association) · 2019-03-30

咳嗽基层诊疗指南（2018年）

中华医学会(CMA,Chinese Medical Association) · 2019-03-20

2018 CHEST指南：成人和儿童百日咳相关咳嗽的临床诊断

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2018-10-12

2018 CHEST指南：间质性肺病相关性咳嗽的治疗

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2018-07-20

2017 CHEST指南：结核病和其他慢性感染引起的咳嗽

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2017-11-28

韩国咳嗽指南：建议及概要声明（中文版）

暂未更新 · 2016-06-12